✦ LIBER ✦

Ruxolitinib: A New Treatment Option for Myelofibrosis

✍ Scribed by Ganetsky, Alex

Book ID: 118765826
Publisher: John Wiley and Sons
Year: 2013
Tongue: English
Weight: 80 KB
Volume: 33
Category: Article
ISSN: 0277-0008
DOI: 10.1002/phar.1165

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ruxolitinib treatment for myelofibrosis

✍ Jame Abraham 📂 Article 📅 2012 🏛 Frontline Medical Communications, Inc. 🌐 English ⚖ 725 KB

Ruxolitinib: The First FDA Approved Ther

Ruxolitinib: The First FDA Approved Therapy for the Treatment of Myelofibrosis

✍ Mascarenhas, J.; Hoffman, R. 📂 Article 📅 2012 🏛 American Association for Cancer Research 🌐 English ⚖ 428 KB

A Double-Blind, Placebo-Controlled Trial

A Double-Blind, Placebo-Controlled Trial of Ruxolitinib for Myelofibrosis

✍ Verstovsek, Srdan; Mesa, Ruben A.; Gotlib, Jason; Levy, Richard S.; Gupta, Vikas 📂 Article 📅 2012 🏛 Massachusetts Medical Society 🌐 English ⚖ 679 KB

Ruxolitinib for myelofibrosis therapy: c

Ruxolitinib for myelofibrosis therapy: current context, pros and cons

✍ Pardanani, A 📂 Article 📅 2012 🏛 Nature Publishing Group 🌐 English ⚖ 141 KB

Conventional and New Treatment Options f

Conventional and New Treatment Options for Myelofibrosis With Myeloid Metaplasia

✍ Olatoyosi Odenike; Ayalew Tefferi 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 159 KB

New Drugs for the Treatment of Myelofibr

New Drugs for the Treatment of Myelofibrosis

✍ Ruben A. Mesa 📂 Article 📅 2010 🏛 Current Science Inc. 🌐 English ⚖ 197 KB